Across TCGA pan-cancer cohorts, PCDHGA10 mass-spec protein differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of PCDHGA10’s most consistent transcriptional readouts.
The strongest signal is observed in lung squamous cell carcinoma (LSCC), where PCDHGA10 mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types PCDHGA10 is over-expressed in tumor, although a few such as LSCC and LUAD show the opposite, repressed pattern.
LSCC and LUAD are the cancer types where PCDHGA10 tumor–normal differential expression is most reproducible.